Tag: grant
-
State Grant Supports Osteoarthritis Gene Therapy Trial
A California state agency is funding a clinical trial of an experimental gene therapy for reducing inflammation in knee joints of people with osteoarthritis.
-
Biotech to Synthesize Proteins in Microgravity
A biotechnology company synthesizing pure proteins from DNA is preparing to test its process in weightless conditions on the International Space Station.
-
NIH Award Funds A.I. to Detect Alzheimer’s in Clinical Notes
A small-business grant to a developer of natural language analytics for health care aims to detect evidence of cognitive decline from physicians’ notes in electronic health records.
-
Autism Device Company Gains Venture Funds, Joins Incubator
A new company creating precision light-activated treatments for autism spectrum disorder symptoms is raising more seed funds and joining a start-up incubator program.
-
CEPI Assessing Advanced RNA Nanoparticle Vaccine
An international health organization is evaluating a new type of vaccine made with biodegradable RNA nanoparticles to help head off future viral pandemics.
-
Audio Digital Biomarkers Start-Up Raises $3.7M in Seed Funds
A new company developing techniques to analyze internal physiological sounds captured by stethoscopes as health indicators is raising $3.7 million in seed funds.
-
AI-Aided System to Identify Diabetes Complication Risks
Researchers at University of Houston are creating a system aided by algorithms for primary care physicians to better identify people at risk for complications from diabetes.
-
Grant Funds Regenerative Gel for Treating Skin Ulcers
A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers.
-
New Funds Awarded for Rapid Infection Diagnostics
A developer of faster infection diagnostics is receiving another $8.2 million from an international group supporting solutions to antibiotic resistant microbes.
-
Nasal Spray Vaccines Get CEPI, NIH Funding
A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea.